BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14604648)

  • 1. Semi-synthesis, topoisomerase I and kinases inhibitory properties, and antiproliferative activities of new rebeccamycin derivatives.
    Moreau P; Gaillard N; Marminon C; Anizon F; Dias N; Baldeyrou B; Bailly C; Pierré A; Hickman J; Pfeiffer B; Renard P; Prudhomme M
    Bioorg Med Chem; 2003 Nov; 11(23):4871-9. PubMed ID: 14604648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rebeccamycin analogues as anti-cancer agents.
    Prudhomme M
    Eur J Med Chem; 2003 Feb; 38(2):123-40. PubMed ID: 12620658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, structure-activity relationship, and biological studies of indolocarbazoles as potent cyclin D1-CDK4 inhibitors.
    Zhu G; Conner SE; Zhou X; Shih C; Li T; Anderson BD; Brooks HB; Campbell RM; Considine E; Dempsey JA; Faul MM; Ogg C; Patel B; Schultz RM; Spencer CD; Teicher B; Watkins SA
    J Med Chem; 2003 May; 46(11):2027-30. PubMed ID: 12747775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, mode of action, and biological activities of rebeccamycin bromo derivatives.
    Moreau P; Anizon F; Sancelme M; Prudhomme M; Sevère D; Riou JF; Goossens JF; Hénichart JP; Bailly C; Labourier E; Tazzi J; Fabbro D; Meyer T; Aubertin AM
    J Med Chem; 1999 May; 42(10):1816-22. PubMed ID: 10346933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analogues of antifungal tjipanazoles from rebeccamycin.
    Voldoire A; Moreau P; Sancelme M; Matulova M; Léonce S; Pierré A; Hickman J; Pfeiffer B; Renard P; Dias N; Bailly C; Prudhomme M
    Bioorg Med Chem; 2004 Apr; 12(8):1955-62. PubMed ID: 15051063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological activities of 7-aza rebeccamycin analogues bearing the sugar moiety on the nitrogen of the pyridine ring.
    Messaoudi S; Anizon F; Peixoto P; David-Cordonnier MH; Golsteyn RM; Léonce S; Pfeiffer B; Prudhomme M
    Bioorg Med Chem; 2006 Nov; 14(22):7551-62. PubMed ID: 16889964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syntheses and antiproliferative activities of new rebeccamycin derivatives with the sugar unit linked to both indole nitrogens.
    Marminon C; Anizon F; Moreau P; Léonce S; Pierré A; Pfeiffer B; Renard P; Prudhomme M
    J Med Chem; 2002 Mar; 45(6):1330-9. PubMed ID: 11882002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxicities of three rebeccamycin derivatives in the National Cancer Institute screening of 60 human tumor cell lines.
    Moreau P; Holbeck S; Prudhomme M; Sausville EA
    Anticancer Drugs; 2005 Feb; 16(2):145-50. PubMed ID: 15655411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indolocarbazole glycosides in inactive conformations.
    Facompré M; Carrasco C; Vezin H; Chisholm JD; Yoburn JC; Van Vranken DL; Bailly C
    Chembiochem; 2003 May; 4(5):386-95. PubMed ID: 12740810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syntheses and biological activities of rebeccamycin analogues with uncommon sugars.
    Zhang G; Shen J; Cheng H; Zhu L; Fang L; Luo S; Muller MT; Lee GE; Wei L; Du Y; Sun D; Wang PG
    J Med Chem; 2005 Apr; 48(7):2600-11. PubMed ID: 15801850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rebeccamycin analogues bearing amine substituents or other groups on the sugar moiety.
    Anizon F; Moreau P; Sancelme M; Laine W; Bailly C; Prudhomme M
    Bioorg Med Chem; 2003 Aug; 11(17):3709-22. PubMed ID: 12901916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological evaluation, and molecular modeling studies of rebeccamycin analogues modified in the carbohydrate moiety.
    Animati F; Berettoni M; Bigioni M; Binaschi M; Felicetti P; Gontrani L; Incani O; Madami A; Monteagudo E; Olivieri L; Resta S; Rossi C; Cipollone A
    ChemMedChem; 2008 Feb; 3(2):266-79. PubMed ID: 18157856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rebeccamycin analogues from indolo[2,3-c]carbazole.
    Voldoire A; Sancelme M; Prudhomme M; Colson P; Houssier C; Bailly C; Léonce S; Lambel S
    Bioorg Med Chem; 2001 Feb; 9(2):357-65. PubMed ID: 11249128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntheses and biological activities (topoisomerase inhibition and antitumor and antimicrobial properties) of rebeccamycin analogues bearing modified sugar moieties and substituted on the imide nitrogen with a methyl group.
    Anizon F; Belin L; Moreau P; Sancelme M; Voldoire A; Prudhomme M; Ollier M; Sevère D; Riou JF; Bailly C; Fabbro D; Meyer T
    J Med Chem; 1997 Oct; 40(21):3456-65. PubMed ID: 9341921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel 5-azaindolocarbazoles as cytotoxic agents and Chk1 inhibitors.
    Lefoix M; Coudert G; Routier S; Pfeiffer B; Caignard DH; Hickman J; Pierré A; Golsteyn RM; Léonce S; Bossard C; Mérour JY
    Bioorg Med Chem; 2008 May; 16(9):5303-21. PubMed ID: 18342518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anticancer activity of new pyrrolocarbazoles and pyrrolo-beta-carbolines.
    Laronze M; Boisbrun M; Léonce S; Pfeiffer B; Renard P; Lozach O; Meijer L; Lansiaux A; Bailly C; Sapi J; Laronze JY
    Bioorg Med Chem; 2005 Mar; 13(6):2263-83. PubMed ID: 15830466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syntheses and biological evaluation of indolocarbazoles, analogues of rebeccamycin, modified at the imide heterocycle.
    Moreau P; Anizon F; Sancelme M; Prudhomme M; Bailly C; Carrasco C; Ollier M; Sevère D; Riou JF; Fabbro D; Meyer T; Aubertin AM
    J Med Chem; 1998 May; 41(10):1631-40. PubMed ID: 9572888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of novel phenylcarbazoles as potential anticancer agents.
    Routier S; Mérour JY; Dias N; Lansiaux A; Bailly C; Lozach O; Meijer L
    J Med Chem; 2006 Jan; 49(2):789-99. PubMed ID: 16420063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
    Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
    J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA targeting of two new antitumour rebeccamycin derivatives.
    Facompré M; Baldeyrou B; Bailly C; Anizon F; Marminon C; Prudhomme M; Colson P; Houssier C
    Eur J Med Chem; 2002 Dec; 37(12):925-32. PubMed ID: 12660017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.